Literature DB >> 11465022

Treatable lower motor neuron disease due to vitamin D deficiency and secondary hyperparathyroidism.

C H Whitaker1, C D Malchoff, K J Felice.   

Abstract

Vitamin D deficiency and osteomalacia are frequently associated with muscle weakness and atrophy. We present a 78-year-old man with complaints of progressive painless weakness who was referred to us with a diagnosis of suspected motor neuron disease. Results of the neurological examination were remarkable, showing diffuse limb weakness and atrophy, rare fasciculations, normal sensory examination, no bulbar weakness, and no upper motor neuron signs. Electromyography revealed mild chronic changes, denervation and re-innervation, without fibrillations or positive waves. Serum laboratory studies showed an elevated serum parathyroid hormone and markedly reduced vitamin D level. Although the etiology of the vitamin D deficiency was not determined, the patient made a substantial clinical improvement following vitamin D therapy. Vitamin D deficiency and secondary hyperparathyroidism need to be included in the differential diagnosis of patients presenting with a progressive lower motor neuron disease.

Entities:  

Mesh:

Year:  2000        PMID: 11465022     DOI: 10.1080/14660820050515115

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  3 in total

Review 1.  Electrodiagnosis in persons with amyotrophic lateral sclerosis.

Authors:  Nanette C Joyce; Gregory T Carter
Journal:  PM R       Date:  2013-03-21       Impact factor: 2.298

2.  Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature.

Authors:  Richard A Rison; Said R Beydoun
Journal:  J Med Case Rep       Date:  2010-09-01

3.  Vitamin D status in chronic fatigue syndrome/myalgic encephalomyelitis: a cohort study from the North-West of England.

Authors:  Kate E Earl; Giorgos K Sakellariou; Melanie Sinclair; Manuel Fenech; Fiona Croden; Daniel J Owens; Jonathan Tang; Alastair Miller; Clare Lawton; Louise Dye; Graeme L Close; William D Fraser; Anne McArdle; Michael B J Beadsworth
Journal:  BMJ Open       Date:  2017-11-08       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.